MamaMancini's Holdings Inc (MMMB): MMMB moved to the Nasdaq from the OTC:...

Renee · 2021-07-15T13:13:39.8530000Z

MMMB moved to the Nasdaq from the OTC: https://otce.finra.org/otce/dailyList?viewType=Deletions

Play Episode

6min

Proactive - Interviews for investors

Wrkr CEO on super compliance growth strategy

Wrkr Limited CEO Trent Lund talked with Proactive at the AIM's Small and Midcap Conference about the company’s strategy to simplify compliance through a deeply integrated digital platform. The ASX-listed company, trading under the ticker WRK, connects users, employers, and superannuation funds to streamline data accuracy and reduce friction in onboarding processes. “We do all the hard work and the heavy lifting so the business and the employee don’t have to,” said Lund. He explained that Wrkr verifies user credentials and automates data flows, reducing error and increasing trust. The system connects to major superannuation funds and payroll systems, holding accurate user information even during job transitions. Lund detailed Wrkr’s monetisation model, which aims to earn approximately $7 per user through microservices, including license checks and transactions. Current pilots, including one with major fund REST, are transitioning to production. Each super fund implementation takes about nine months and represents between $7 million and $14 million in annual annuity revenue once fully operational. Looking ahead, 2025 will be focused on large-scale implementation, with 2026 anticipated to generate higher consumption-based revenues. In 2027, Wrkr expects a significant uplift with the introduction of payday super legislation. #WrkrLimited #TrentLund #ASXWRK #Superannuation #ComplianceTech #FintechAustralia #PayrollIntegration #InvestorUpdate #PaydaySuper #DigitalTransformation #DataVerification #WorkforceAutomation

Proactive - Interviews for investors

Digitalbox CEO James Carter on strong 2024 growth and 2025 outlook

Digitalbox PLC (AIM:DBOX) CEO James Carter takes Proactive's Stephen Gunnion through the company’s strong 2024 performance and its strategy heading into 2025. The company delivered a 31% increase in revenue during the year, with Carter describing it as “a good turnaround year.” He pointed to audience growth that outperformed broader news media trends, and revenue growth that exceeded global digital advertising market averages. Carter credited the success to the strength of Digitalbox’s brands and editorial teams, as well as the company’s in-house Graphene Ad Stack technology. “The editorial teams are really very well tuned into what their audiences want,” he said. Among standout performers were TV Guide, which achieved 90% traffic growth in Q4 following a move to a web app format, and The Tab, which benefited from social media asset integration. The Poke also saw a 22% increase in traffic following increased content investment. The company expanded its portfolio from six to eight brands in 2024, aiming to reach ten by the end of 2025. Looking ahead, Carter said 2025 is in line with expectations so far, and Digitalbox remains “cautiously optimistic” amid projected 10% growth in the digital ad market. Visit Proactive’s YouTube channel for more videos, and don’t forget to give the video a like, subscribe to the channel and enable notifications for future content. #Digitalbox #JamesCarter #MediaGrowth #DigitalAdvertising #TVGuide #TheTab #OnlineMedia #RevenueGrowth #AdTech #MediaBrands #InvestorUpdate #ProactiveInvestors

Proactive - Interviews for investors

Thor Explorations says Douta-West discovery adds gold ounces for upcoming PFS

Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF) CEO Segun Lawson talked with Proactive's Stephen Gunnion about progress at the Douta gold project in Senegal, with a specific focus on the Douta-West licence. Lawson outlined that Thor acquired the licence a year ago and has since been advancing drilling efforts there. He confirmed the company has now made a fresh discovery, which includes oxide, free-flowing, recoverable gold material. “These are wide intersections between 12 and 20 metres wide, with very good grades between 1.3 and just over 2 grams per ton,” Lawson said. He added that the anomaly runs for approximately two kilometres and could be a significant contributor to the overall economics of the project. Lawson noted that the next step is to fully drill the strike length of the discovery zone. This will allow the company to include the newly identified ounces into its mine plan and potentially enhance the preliminary feasibility study (PFS). He also highlighted that the company is not pursuing exploration for academic purposes, but rather with a clear intent to build and deliver value to shareholders. Lawson confirmed that following the completion of the drilling campaign, Thor will provide an updated timeline for the PFS. Watch the full interview for more insights, and don’t forget to like this video, subscribe to Proactive’s YouTube channel, and turn on notifications for future updates. #ThorExplorations #GoldDiscovery #MiningUpdate #SenegalMining #DrillResults #DoutaProject #GoldStocks #PFS #JuniorMining #ResourceExpansion

Proactive - Interviews for investors

Genflow Biosciences CEO welcomes new investment; outlines dog longevity trial

Genflow Biosciences PLC CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about a pivotal new direction for the company as it initiates a clinical trial focused on improving aging in dogs. Leire described the trial as a natural evolution from Genflow's previous success in mice, noting the commercial appeal of the canine market. “There is nothing to improve really the quality of life of our aging dogs,” he said, adding that the study meets a significant unmet need. The trial will run for one year, with six months of treatment followed by six months of assessment. It's being managed by independent contract research organisation Syngene. Leire emphasised the scientific rigour of the trial, which is controlled, randomised and includes both aesthetic and biological endpoints. These include coat quality, mitochondrial function, and methylation clocks — all of which have potential crossover value for human applications. Leire also highlighted the company’s differentiated approach compared to US competitors using repurposed drugs like metformin. Genflow, he said, is pursuing gene therapy with the potential for greater impact. The investment supporting the trial, although limited in size, is seen as a strategic vote of confidence, bringing in credible investors from outside the UK, including the US. Leire described the initiative as a major step that could generate near-term revenue and redefine the company’s biotech positioning. For more company updates, visit Proactive's YouTube channel. Don’t forget to like the video, subscribe to the channel, and hit the notification bell for future content. #GenflowBiosciences #GeneTherapy #DogAging #BiotechInvestment #LongevityResearch #Mitochondria #PetHealth #ClinicalTrials #AgingDogs #BiotechNews

Followers	1519
Posts	36159
Boards Moderated	7
Alias Born	07/12/2004

Volume:	-
Day Range:
Bid:	3.74
Ask:	3.85
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

MMMB Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free